Mirati Therapeutics, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2012 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Mirati Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2012 to 2022.
  • Mirati Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $1.73M, a 31.7% decline year-over-year.
  • Mirati Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $167M, a 67% decline from 2021.
  • Mirati Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $505M, a 59.6% decline from 2020.
  • Mirati Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $1.25B, a 270% increase from 2019.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $167M -$338M -67% Jan 1, 2022 Dec 31, 2022 10-K 2023-02-28
2021 $505M -$745M -59.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 $1.25B +$913M +270% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $338M +$197M +140% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $141M -$17.8M -11.2% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $159M +$156M +5883% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 $2.65M -$142M -98.2% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $144M +$143M +16176% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-08
2014 $887K -$53.9M -98.4% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-09
2013 $54.8M +$29.9M +121% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-09
2012 $24.8M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.